Abstract

BackgroundLeukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) is a collagen receptor belonging to the immunoglobulin superfamily. Although previous studies have evaluated the biological role of LAIR in solid tumors, the precise mechanisms underlying the functions of LAIR-1 as a regulator of tumor biological functions remain unclear.MethodsLAIR-1 expression was evaluated by immunohistochemical analysis using an osteosarcoma (OS) tissue microarray. Wound healing and transwell migration assays were performed to evaluate tumor cell migration. Quantitative real-time polymerase chain reaction (qPCR) and western blotting were conducted to detect the expression of epithelial–mesenchymal transition (EMT)-related molecules. RNA-sequencing (RNA-seq) was conducted to evaluate the mRNA expression profiles after overexpressing LAIR-1 in OS cells. Glucose transporter (Glut)1 expression in OS cells was evaluated by western blotting.ResultsLAIR-1 expression was significantly different between the T1 and T2 stages of OS tumors, and it inhibited OS cell migration. LAIR-1 expression was inversely correlated with the expression of Twist1, an EMT-associated transcription factor, via the Forkhead box O1 signal transduction pathway. Furthermore, RNA-seq and qPCR demonstrated that the expression of EMT energy metabolism-related molecules was significantly reduced after LAIR-1 overexpression.ConclusionsLAIR-1 overexpression decreased the expression of Glut1 and inhibited the expression of EMT-related molecules in OS cells. These findings provide new insights into the molecular mechanism underlying OS progression.

Highlights

  • Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) is a collagen receptor belonging to the immunoglobulin superfamily

  • We investigated the association between LAIR-1 overexpression and human OS tumor growth and examined whether LAIR-1 overexpression exhibits a compensatory effect to help overcome OS progression

  • The results indicated that the migration ability of OS cells treated with LV-LAIR-1 was drastically lower than that of untreated blank cells and cells treated with LV-negative control (NC) (Fig. 2c, d)

Read more

Summary

Introduction

Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) is a collagen receptor belonging to the immunoglobulin superfamily. Previous studies have evaluated the biological role of LAIR in solid tumors, the precise mechanisms underlying the functions of LAIR-1 as a regulator of tumor biological functions remain unclear. Osteosarcoma (OS) is the most common malignant solid bone tumor in children and young adults, accounting for 6% of all pediatric cancers and typically originating in the metaphyses of long bones [1, 2]. Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1; known as CD305) is a collagen receptor and member of the immunoglobulin superfamily [8]. LAIR-1 has been indicated to play important roles in different types of cancers, including leukemia and solid tumors [10,11,12,13,14]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call